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Abstract
Background: Acutely ill patients are a heterogeneous group, and some of these suffer from organ failure. As the
prognosis of organ failure improves with early treatment, it is important to identify these patients as early as possible.
Most studies on organ failure have been performed in intensive care settings, or on selected groups of patients, where
a high prevalence and mortality have been reported. Before patients arrive to the intensive care unit, or the general
ward, most of them have passed through the emergency department (ED), where diagnosis and treatment has been
initiated. The prevalence and prognosis of acutely ill patients, with organ failure, at arrival have been studied in some
selected groups, but methods and results differ. This systematic review aims to identify, summarize, and analyze studies
of prevalence and prognosis of new onset organ failure in acutely ill undifferentiated patients, at arrival to
hospital. The result of the review will assist physicians working in an ED, when assessing patients’ risk of
organ failure and their associated prognosis.
Methods: The information sources used are electronic databases, PubMed, Cochrane Library, EMBASE, and CINAHL;
references in included studies and review articles; and authors’ personal files. One author will perform the title and
abstract screening and exclude obviously ineligible studies. By an independent full-text screening, two authors will
decide on the eligibility for the remaining studies. Eligible studies will include an unselected group of acutely ill adult
patients at arrival to hospital, with one or more organ failures (respiratory, renal, cerebral, circulatory, hepatic,
or coagulation failure). Included studies will have assessed the prevalence or prognosis, defined as mortality
or ICU transfer, of new onset organ failure. From included studies, bibliographical and study description data,
patient characteristics, and data related to prevalence of organ failure and prognosis will be extracted. We will assess risk
of bias in included studies using the Quality in Prognosis Studies tool for prognostic studies and the Newcastle-Ottawa
Scale for observational studies. We expect heterogeneity and to conduct a qualitative synthesis of the results. If, however,
heterogeneity is low, we will conduct a random effects meta-analysis stratified by basic study design.
Discussion: This review will summarize and analyze studies of prevalence and prognosis of acutely ill patients, with
organ failure at arrival to hospital, assist ED physicians assessing the risk of organ failure in unselected patients, and
guide recommendations for further research.
Systematic review registration: PROSPERO CRD42017060871
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Background
Patients arriving with an acute condition are a heteroge-
neous group, and the initial step is to identify the critic-
ally ill. Some patients have organ failures based on
different etiologies, affecting different organs with
diverse severity, and identifying these is also a priority.
Most of the existing knowledge regarding organ failure
has been obtained in intensive care settings or on
selected groups of patients, not on undifferentiated
patients at the hospital doorstep, but later on.
Studies on patients in intensive care units (ICU) have
reported a high prevalence of at least one organ failure
(51–72%) at some point during the ICU stay. Respiratory
organ failure is most prevalent, affecting as many as 87%
organ failure patients. Prognosis described as in-hospital,
short-term, and long-term mortality depends on the
severity of organ dysfunction, number of failing organs,
and the specific organ affected, and 5-year mortality is
described at approximately 60% [1–4].
Outside the ICU, prevalence of organ failure, in unse-
lected ward patients or after injury in US trauma and non-
trauma centers, is described at approximately 7–14%. In
undifferentiated patients with shock, the presence of
organ failures has been described as 70%, at arrival to the
emergency department. Organ failure is associated with
increased in-hospital mortality, which increases with each
additional organ failure, ranging from 12 to 60% with one
to more than three organ failures [5–7].
Organ failure or the number of organ failures is also a
risk factor in patients with severe sepsis [8]. There has
been demonstrated an association between increasing
number of organ failures and increased in-hospital,
short-term, and long-term mortality and an association
with ICU transfer from the emergency department. Like-
wise, it has been demonstrated that presence of clinically
recognizable signs of organ failure results in better treat-
ment compared to organ-specific laboratory values. The
most common organ failures have been described as
cardiovascular, renal, and respiratory [9–13]. Sepsis
survivors have showed rates of persistent and long-term
(≥ 90 days) organ dysfunction to be no less than 27 and
21% respectively [14].
Patients suffering from organ failure have to be identi-
fied and treated as early as possible. Before patients arrive
to the ICU or general ward, most have passed the emer-
gency department (ED) where the ED doctors have treated
or started treatment due to acute illness. Furthermore,
identifying patients at greatest risk for chronic organ
failure is important, because it will allow early identifica-
tion of susceptible patients which needs preventive inter-
ventions [14]. By this systematic review, we wish to
identify, summarize, and analyze studies on the prevalence
and prognosis of new onset organ failure in acutely ill un-
differentiated patients at arrival on the hospital doorstep.
Methods/design
We plan to conduct a systematic review. This proto-
col is reported according to the Preferred Reporting
Items for Systematic Reviews and Meta-Analysis
Protocols (PRISMA-P) 2015 statement (see checklist
in Additional file 1) and developed with inspiration
from the Cochrane Handbook for Systematic Reviews
of Interventions [15–17].
Objectives
Our overall aim is to assess the prevalence and prog-
nosis of new organ failures in acutely ill patients at
arrival to hospital. Our main research objective is to
assess (1) the prevalence of new onset organ failures
in acutely ill patients at arrival to hospital and (2) the
prognosis of patients with newly onset organ failure
at arrival to hospital.
Eligibility criteria
Study designs
We will include observational studies (cross-sectional
studies, prospective and retrospective cohort studies,
and case-control studies), and randomized and non-
randomized controlled trials, assessing the prevalence of
new organ failure, or prognosis of acutely ill patients at
hospital arrival. We will exclude case reports and studies
with less than 100 patients.
Participants/population
Eligible studies will include an unselected group of
acutely ill adult patients. Studies on selected groups of
patients, such as specific conditions or diseases, will be
excluded. Studies not restricted to adults are eligible and
will be included in our analyses, provided that separate
adult-data evaluation is achievable.
Studies on acutely ill patients, with one or more of the
following organ failures, will be included: respiratory
failure, renal failure, cerebral failure, circulatory failure,
hepatic failure, or coagulation failure.
Outcomes
Studies that assess the prevalence of one or more organ
failures, disregarding how prevalence has been defined
or measured, will be included. Studies that have assessed
prognosis, defined as mortality (short-term, long-term,
and all-cause mortality and organ failure-specific
mortality) or ICU transfer, will be included as well.
Included studies may have dissimilar definitions of
organ failures and may define short-term and long-
term mortality by different thresholds. We will adhere
to the organ failure definition as reported in the indi-
vidual study and aim to extract mortality data as
close as possible for 30-day and 1-year mortality.
Pedersen et al. Systematic Reviews  (2017) 6:227 Page 2 of 5
Setting
We will include studies of patients which arrive to
hospital at an emergency department, a trauma centre, a
general ward, an acute medical unit, or other entrances
for acutely ill patients. Studies where patients arrive
directly at an intensive care unit are excluded.
Language
Studies published or conducted in English, or other
languages the author group are able to read, will be
included. Study titles in other languages will be listed
and provided as an appendix if they seem relevant.
Information sources
Information sources used are electronic databases not
restricted to a specific period of time, references in
included studies and review articles, and authors’ personal
files. The databases we will use are PubMed, Cochrane
Library, EMBASE, and CINAHL, and the protocol
database, PROSPERO, will be searched for ongoing or
recently completed systematic reviews on similar topics.
Search strategy
Search strategy for the databases will be developed itera-
tively by the input from all the members of the project
team and with the help from an information specialist
from The Medical Research Library at the University of
Southern Denmark in a face-to-face meeting.
We will systematically scan the reference lists of
included studies or reviews for eligible studies and
inspect authors’ personal files. We will not contact
content experts for a list of possibly eligible studies.
When a search has been performed at one electronic
database, the same search will be performed at the other
databases and only adapt the exact subjects and
syntax, which fit in that particular database. Just
before finalizing the review, the search will be up-
dated to ensure the most recent relevant studies are
included. To increase transparency, a research record
table (Table 1) will be included.
Draft PubMed:
Organ failure
Organ failure OR organ failures
Organ failure OR organ failures OR organ dysfunction
Organ failure OR organ failures OR organ dysfunction
OR organ dysfunctions
Organ failure OR organ failures OR organ dysfunction
OR organ dysfunctions OR organ system dysfunction
Organ failure OR organ failures OR organ dysfunction
OR organ dysfunctions OR organ system dysfunction
AND emergency department
Organ failure OR organ failures OR organ dysfunction
OR organ dysfunctions OR organ system dysfunction
AND (emergency department OR emergency room)
Organ failure OR organ failures OR organ dysfunction
OR organ dysfunctions OR organ system dysfunction
AND (emergency department OR emergency room OR
acute medical unit)
Organ failure OR organ failures OR organ dysfunction
OR organ dysfunctions OR organ system dysfunction
AND (emergency department OR emergency room OR
acute medical unit OR non-ICU)
Study records
Data management
References, from the literature search, will be exported
to the software program “Endnote,” where a check for
duplicates is performed. Afterwards, references are
transferred to the software program “Covidence.org” for
further processing. An internal study audit will be
performed on studies conducted by identical authors to
avoid double counting, and studies on identical data will
be compared to clarify inconsistencies.
Selection process
PBP will perform title and abstract screening and
exclude obviously ineligible studies. Other studies will be
read in full length, independent, and in duplicate by two
review authors, PBP and DLN. Subsequently, in agree-
ment, the two review authors will decide whether the
study meets inclusion criteria. The proportion of agree-
ment is presented in the final review. Disagreements will
be discussed at a face-to-face meeting, and in the case of
continued disagreements, AH and ATL’s point of view
will decide for the inclusion. Reasons for excluding full--
text studies will be documented.
Data collection process and data items
From included studies, we will extract bibliographical
and study description data, patient characteristics, and
data related to prevalence of organ failure and prognosis.
Data extraction will be performed, independent and in
duplicate by two reviewers, using predefined data fields.
After pilot data extraction involving two to three studies,
the data extraction sheet will be revised. In case of
discrepancies, the rest of the review group is involved. In
the absence of complete description of data or out-
comes, we will attempt to establish contact to the
authors by e-mail, as many as three times.
Table 1 Research record table
Information source Date searched Search References Comments
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Outcomes and prioritization
The primary outcome will be number of organ failures,
and patients with organ failures at arrival (first recorded
vital and laboratory values within 24 h or as close as
possible) per 1000 visits. Organ failures studied are re-
spiratory, circulatory, renal, hepatic, coagulatory, and
cerebral, with any definition per original paper.
The secondary outcome, for patients with organ
failure, is prognosis, assed by proportion and relative risk
of transfer to ICU and/or 30-day (or as close as possible)
and 1-year (or as close as possible) all-cause mortality.
Risk of bias in individual studies
To assess the risk of bias within included studies, the
Quality in Prognosis Studies (QUIPS) tool for prognostic
studies, the Newcastle-Ottawa Scale (NOS) for observa-
tional studies, and the Cochrane Risk of Bias Tool
(CRBT) for randomized controlled trials will be used.
The QUIPS tool rates six bias domains: study participa-
tion, study attrition, prognostic factor measurement,
outcome measurement, study confounding, and statis-
tical analysis and reporting, as having high, moderate, or
low risk of bias [18]. The NOS evaluate selection, com-
parability, and outcome in case-control and cohort stud-
ies by assigning stars [19]. The CRBT rates the
following: selection bias, performance bias, detection
bias, attrition bias, reporting bias, and other biases as
low, high, or unclear [20]. Two independent reviewers,
PBP and DLN, will assess every included study for bias;
neither of the assessors is blinded to the studies, and
disagreements will be resolved by discussion and eventually
by consulting ATL and AH from the review group.
Data synthesis
On basis of scoping searches conducted in preparation
for this review, we do not anticipate to conduct a meta-
analysis, as considerable diversity in studies to be
included is expected. In any case, we will explore
reasons for the expected heterogeneity according to clin-
ical (participants and outcomes) and methodological
(design and risk of bias) characteristics. Statistical test
for heterogeneity will be performed (Cochran’s Q), and
degree of heterogeneity will be described with the I2
statistic. In the case of substantial and statistically
significant heterogeneity (I-square > 60%, P < 0.10), a
meta-analysis with the aim of assessing a weighted average
will not be performed [21].
If heterogeneity is low, contrary to expectation, we will
conduct a random effects meta-analysis, stratified by
basic study design. We will present both synthetic and
analytic views and try to explain heterogeneity by study
characteristics and population characteristics.
We anticipate to perform a qualitative synthesis of the
included studies (reporting median and interquartile
results) based on tables and graphs to sum up results
and findings. The synthesis will include basic study
characteristics, results (including heterogeneity), risk
of bias assessments, and explorations of reasons for
heterogeneity [22].
In subgroups of patients with organ failure following
trauma, bleeding, cardiac failure, or sepsis, sub-group
analysis will be performed based on patient characteristics,
types, and numbers of organ failure.
Confidence in cumulative evidence
We will assess certainty of evidence provided by our
review, inspired by the Grading of Recommendations
Assessment (GRADE approach) depending on the
basic design of the included studies and any down-
or upgrading decisions as high, moderate, low, or very
low. We will use the following assessment criteria
when considering downgrading the certainty of the
evidence: risk of bias, inconsistency, indirectness,
imprecision, and publication bias to decide how to
grade the certainty of evidence [23, 24]. As our study
is observational by nature and do not address effect,
we will not upgrade evidence based on standard
criteria. The assessments will be performed by two
review authors, PBP and DLN, independently, and
disagreements will be resolved by discussion.
Amendments
In case of protocol amendments, a table will be added with
a description of every change, the rationale, and a date.
Changes will not be incorporated into the protocol. Signifi-
cant amendments will be registered in the PROSPERO
register, and approval by all authors is required prior to
registration. The review will contain a section describing
differences between protocol and review.
Discussion
The overarching goal of this review is to summarize data
on prevalence and prognosis for acutely ill patients with
organ failure at arrival to hospital. As early identification
and treatment of these patients improves prognosis,
systematic knowledge of the epidemiology might help
clinical treatment in the emergency department. This
has the potential to change the direct clinical manage-
ment, as well as provide information of where to
increase resources for the immediate management of
acutely ill patients with organ failure.
This systematic review is planned to be published in a
peer-reviewed journal.
Additional file
Additional file 1: PRISMA-P 2015 checklist. (DOCX 35 kb)
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